Skip to main navigation Skip to search Skip to main content

Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial

  • Noémie Mercier
  • , Drifa Belhadi
  • , Aline DeChanet
  • , Christelle Delmas
  • , Juliette Saillard
  • , Marina Dumousseaux
  • , Soizic Le Mestre
  • , Claire Fougerou-Leurent
  • , Assia Ferrane
  • , Charles Burdet
  • , Hélène Espérou
  • , Florence Ader
  • , Maya Hites
  • , Nathan Peiffer-Smadja
  • , Julien Poissy
  • , Claire Andrejak
  • , José Artur Paiva
  • , Evelina Tacconelli
  • , Thérèse Staub
  • , Richard Greil
  • Dominique Costagliola, France Mentre, Yazdan Yazdanpanah, Alpha Diallo, DisCoVeRy Safety Working group, Nassera Aouali

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases